Optimal approach for renal cancer

por Sternberg, Cora N.
Publicado 2013

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

por Sternberg, Cora N
Publicado 2016

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer

por Recine, Federica, Sternberg, Cora N.
Publicado 2015

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2016

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2017

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2017

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2017

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2018

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2018

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2018

Clinical Trials Corner

por Agarwal, Piyush K., Sternberg, Cora N.
Publicado 2018

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer

por Rodriguez-Vida, Alejo, Galazi, Myria, Rudman, Sarah, Chowdhury, Simon, Sternberg, Cora N
Publicado 2015

Treatment patterns and characteristics of European patients with castration-resistant prostate cancer

por Sternberg, Cora N, Baskin-Bey, Edwina S, Watson, Mark, Worsfold, Andrew, Rider, Alex, Tombal, Bertrand
Publicado 2013

Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study

por Molina, Ana M., Hutson, Thomas E., Nosov, Dmitry, Tomczak, Piotr, Lipatov, Oleg, Sternberg, Cora N., Motzer, Robert, Eisen, Tim
Publicado 2018

Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate c...

por Shore, Neal, Higano, Celestia S., George, Daniel J., Sternberg, Cora N., Saad, Fred, Tombal, Bertrand, Miller, Kurt, Kalinovsky, Jan, Jiao, XiaoLong, Tangirala, Krishna, Sartor, Oliver
Publicado 2020

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-...

por Suzuki, Hiroyoshi, Castellano, Daniel, de Bono, Johann, Sternberg, Cora N, Fizazi, Karim, Tombal, Bertrand, Wülfing, Christian, Foster, Meredith C, Ozatilgan, Ayse, Geffriaud-Ricouard, Christine, de Wit, Ronald
Publicado 2021

The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial

por Zhao, Jimmy L., Fizazi, Karim, Saad, Fred, Chi, Kim N., Taplin, Mary-Ellen, Sternberg, Cora N., Armstrong, Andrew J., de Bono, Johann S., Duggan, William T., Scher, Howard I.
Publicado 2022

An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors

por Paola, Eugenio Donato Di, Alonso, Silvia, Giuliani, Rosa, Calabrò, Fabio, D’Alessio, Antonietta, Regine, Giovanni, Cerbone, Linda, Bianchi, Laura, Mancuso, Andrea, Sperka, Sabine, Rozencweig, Marcel, Sternberg, Cora N.
Publicado 2012

Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVA...

por Armstrong, Andrew J., Al-Adhami, Mohammed, Lin, Ping, Parli, Teresa, Sugg, Jennifer, Steinberg, Joyce, Tombal, Bertrand, Sternberg, Cora N., de Bono, Johann, Scher, Howard I., Beer, Tomasz M.
Publicado 2019

The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials

por Tombal, Bertrand, Stenzl, Arnulf, Cella, David, Loriot, Yohann, Armstrong, Andrew J., Fizazi, Karim, Beer, Tomasz, Sternberg, Cora N., Hussain, Maha, Ivanescu, Cristina, Ganguli, Arijit, Ramaswamy, Krishnan, Saad, Fred
Publicado 2021